Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.61 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Liabilities and Shareholders Equity (2015 - 2026)

Updated

Scinai Immunotherapeutics (SCNI) posted Liabilities and Shareholders Equity of $17.18 million for Q2 2026, up 45.1% from $11.84 million a year earlier but down 2.3% from the prior quarter.

Analysis

Scinai Immunotherapeutics (SCNI) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

At the end of FY2025, Scinai Immunotherapeutics' Liabilities and Shareholders Equity came in at $11.63 million, down 13.5% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
  • In prior years, Scinai Immunotherapeutics' Liabilities and Shareholders Equity was $13.45 million in FY2024 (-23.0%), $17.47 million in FY2023 (-35.4%), $27.07 million in FY2022 (-15.5%) and $32.04 million in FY2021 (+81.0%).
  • Quarterly Liabilities and Shareholders Equity has run from a low of $11.63 million in Q4 2025 to a high of $32.04 million in Q4 2021 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in 1 of the last five quarters, with an average decline of 9.2%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2021, with growth of 81.0%; the weakest was Q4 2023, with a decline of 35.4%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 197.43 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 135.12 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 49.36 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 201.13 Bn
10 Scinai Immunotherapeutics 211,561.42 -8.06 Mn -1.25 Mn 17.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.18 Mn
Mar 31, 2026 17.59 Mn
Dec 31, 2025 11.63 Mn
Jun 30, 2025 11.84 Mn
Dec 31, 2024 13.45 Mn
Sep 30, 2024 12.26 Mn
Jun 30, 2024 14.85 Mn
Mar 31, 2024 17.05 Mn
Dec 31, 2023 17.47 Mn
Sep 30, 2023 18.58 Mn
Jun 30, 2023 19.90 Mn
Mar 31, 2023 23.29 Mn
Dec 31, 2022 27.07 Mn
Sep 30, 2022 21.09 Mn
Jun 30, 2022 24.74 Mn
Dec 31, 2021 32.09 Mn
Sep 30, 2021 25.19 Mn
Jun 30, 2021 27.07 Mn
Dec 31, 2020 17.71 Mn
Sep 30, 2020 21.74 Mn
API Access

Scinai Immunotherapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SCNI&period=max&api_key=YOUR_API_KEY